EVOLUCARE Technologies S.à.R.L

Evolucare Technologies S. à. R. L is a French company specializing in innovative IT solutions tailored for the healthcare industry, focusing on critical care management and integrated health services.

Founded in 1988 in France, Evolucare Technologies S. à. R. L provides vital software solutions for healthcare providers.

The company underwent a significant strategic shift with its most recent TRADE SALE, where it was acquired by GPI SpA for EUR 108. 8 million on June 29, 2023, representing a key moment in its expansion. The CEO is Philippe Blanco, who has a history of leadership in the tech sector. Evolucare specializes in providing comprehensive IT solutions tailored for the healthcare sector, focusing on critical care, medical imaging, and social healthcare services.

The company's core offerings include modular solutions such as the Patient Record System (DPI), which streamlines patient data management across various healthcare settings, and integrated imaging solutions that encompass RIS, PACS, and MACS for effective management of imaging workflows. Evolucare's products are designed to optimize patient care processes, enhance operational efficiency, and ensure compliance with healthcare regulations. The client base includes hospitals, clinics, and medico-social establishments across international markets, emphasizing their commitment to improving healthcare delivery through innovative technology. These solutions have been developed to address specific challenges faced by healthcare providers, ensuring that end users, including healthcare professionals and administrative staff, can deliver patient care more effectively.

In 2022, Evolucare reported a revenue of EUR 35,040,931. 40 with an EBITDA of EUR 7,373,819. 70, reflecting the company's robust financial performance driven by its subscription-based software solutions and strong client engagement. Following the TRADE SALE to GPI SpA, which occurred on June 29, 2023, the acquired resources will enable Evolucare to expand its software product portfolio and strengthen its presence in the European digital health market.

The focus will be on launching new healthcare IT solutions designed to enhance operational efficiencies, although specific release dates were not disclosed. The funding from the recent acquisition will support these initiatives and facilitate entry into new geographic markets, further advancing the company's strategic growth.